Cleveland BioLabs Enters Into Private Placement Agreement With Strategic Investor for $25M Equity Financing, 6.460M Shares For $3.87/Shr

By: via Benzinga
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into a securities purchase agreement with David Davidovich, a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.